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Abstract
Background: According to the hygiene hypothesis, infections in early life protect from allergic
diseases. However, in earlier studies surrogate measures of infection rather than clinical infections
were associated with decreased frequencies of atopic diseases. Exposure to infection indicating
sub-clinical infection rather than clinical infection might protect from atopic diseases.
Objective: to investigate whether exposure to acute respiratory infections within pregnancy and
the first year of life is associated with atopic conditions at age 5–14 years and to explore when
within pregnancy and the first year of life this exposure is most likely to be protective.
Methods: Historical cohort study: Population level data on acute respiratory infections from the
routine reporting system of the former German Democratic Republic were linked with individual
data from consecutive surveys on atopic diseases in the same region (n = 4672). Statistical analyses
included multivariate logistic regression analysis and polynomial distributed lag models.
Results: High exposure to acute respiratory infection between pregnancy and age one year was
associated with overall reduced odds of asthma, eczema, hay fever, atopic sensitization and total
IgE. Exposure in the first 9 months of life showed the most pronounced effect. Adjusted odds
ratio's for asthma, hay fever, inhalant sensitization and total IgE were statistical significantly reduced
up to around half.
Conclusion: Exposure to respiratory infection (most likely indicating sub-clinical infection) within
pregnancy and the first year of life may be protective in atopic diseases development. The post-
natal period thereby seems to be particularly important.
Introduction
Environmental factors play an important role in the
increasing prevalence of atopic diseases. The observation
of an inverse association between family size and hay
fever prompted the hygiene hypothesis suggesting that the
protective effect of siblings on atopic diseases might be
mediated by infections [1]. Many studies confirmed the
"sibling effect" [2] and the effect of other indirect meas-
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ures of infection like day care attendance [3,4]. Further-
more, they pointed to the existence of a highly sensitive
phase for protection though infection, which is present in
early infancy or even in foetal life [3-8]. Studies measuring
the effect of past infection (as against disease) via IgG anti-
bodies observed protective effects of gastro-intestinal viral
diseases on atopic outcomes [9,10]. However, studies
measuring direct effects of clinical infectious disease on
atopic outcomes predominantly found no protective
effects [6,9-12].
"Sibling effect", day care attendance and IgG antibodies
represent proxy measures for infection overall. However,
these measures do not represent clinical infectious disease
but additionally indicate sub-clinical infection meaning
an immunological reaction of the body without clinical
symptoms of disease. We speculated that maybe not clin-
ical infectious disease but infection (including sub-clini-
cal infection) is responsible for the protective effects on
atopic conditions. Consequently, a higher exposure to
infections in the population (e.g. an epidemic with acute
respiratory infections (ARI)) would increase the likeli-
hood of sub-clinical infection (and clinical disease) of the
individual and – if acting in a vulnerable period – would
be associated with a decreased frequency of atopic condi-
tions in later life.
Thus the objectives of this study were twofold:
- to test whether a high risk of exposure to ARI in preg-
nancy or early infancy is associated with decreased fre-
quencies of asthma, eczema, hay fever, atopic
sensitization and total IgE at age 5–14 years.
- to explore in what period within pregnancy and the first
year of life this exposure is most likely to offer protection.
We used routine data on ARI from the routine reporting
system of the former German Democratic Republic [13] as
a proxy measure for exposure to infections in pregnancy
and early infancy and combined them with data from
consecutive surveys on atopic diseases.
Methods
Study design
This historical cohort study combined exposure informa-
tion on ARI from a routine reporting surveillance system
with subsequent data from 3 cross-sectional studies in the
same region. Data on ARI notifications were drawn from
monthly surveillance data from the district of Magdeburg
[13] located in Saxony-Anhalt within the former German
Democratic Republic. Saxony-Anhalt includes the region
where the surveys were conducted. In the German Demo-
cratic Republic ARI had to be reported to public health
authorities. This was not the case in the Federal Republic
of Germany. With the German reunification in October
1990 registration of ARI ceased. In 1992–1993, 1995–
1996 and 1998–1999 repeated cross-sectional studies on
asthma and allergic diseases were conducted in the areas
Bitterfeld, Zerbst and Hettstedt in the former East German
state of Saxony-Anhalt. All children aged 5–7 (school
entrants), 8–10 (third grade) and 11–14 years (sixth
grade) in Zerbst and Hettstett and a subset of children of
the same age groups in Bitterfeld were invited to partici-
pate in interviews, physical examination and blood collec-
tion. Children participating in the surveys were born
between May 1977 and June 1993. Selection criteria,
study population and study design have been described in
detail before [14,15]. Response rates ranged between
68.6% and 92.2% depending on survey and study centre
[14,15]. Of the 5539 children participating in any survey,
62% children participated in one survey only, 30% in 2
surveys and 7.7% in all three surveys. Children participat-
ing in more than one survey were only included once in
the current analysis. Informed consent was obtained from
the parents of all children. Ethical approval for the study
was obtained from the University of Rostock Ethics Com-
mittee.
Questionnaire data
Questionnaires on atopic diseases, child characteristics,
lifestyle and environmental factors were filled in by the
parents. In children participating in more than one survey
age was as age at the latest survey. Asthma, hay fever and
eczema were defined as reported lifetime doctor diag-
noses of the respective outcomes in any of the question-
naires. High parental education was defined if at least one
parent completed high school. Parental allergy was con-
sidered positive if at least one parent reported a history of
asthma, hay fever or eczema in any survey.
Atopic sensitization
Total IgE and specific IgE against common inhalant aller-
gens (dermatophagoides pteronyssinus, cat, mixed grasses,
birch pollen) were determined by standardized methods
with CAP-RAST FEARI (Pharmacia Diagnostics, Freiburg,
Germany). Inhalant allergen sensitization was defined as
any measured specific IgE values >= 0.70 kU/l. Outdoor
allergen sensitization was defined as specific IgE value
against mixed grasses or birch pollen >= 0.70 kU/l. Indoor
allergen sensitization was defined as specific IgE value
against cat or house dust mite >= 0.70 kU/l. An arbitrary
cut-off of 400 kU/l was chosen to represent elevated total
IgE. This cut-off level was chosen to identify children at
the very high end of total IgE levels while maintaining a
large enough group for statistical analysis. Moreover, we
chose a full and even number as cut-off point.Respiratory Research 2006, 7:81 http://respiratory-research.com/content/7/1/81
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Study population
We restricted the study population to children born
before 1990, because there were no reliable data on ARI
from October 1990 onwards (due to the reunification of
Germany). Therefore only data from children born
between May 1977 and December 1989 were included in
the analysis (n = 4673).
Acute respiratory infections (ARI) [13]
The former German Democratic Republic had a state con-
trolled health system with less than 5% private practition-
ers. Practitioners had to record ARI and other infectious
diseases like malaria, toxoplasmosis, pertussis, listeriosis,
scabies, mononucleosis, amoeba, typhoid, paratyphoid
and tapeworm infections in notification forms that were
passed on to public health authorities. Validation studies
for the reporting system do not exist. However, due to the
state centralised structure of both surveillance system and
reporting physicians a high and regionally stable accuracy
is likely. No distinction was made between the type of ARI
or viral or bacterial origin of ARI. It can be assumed that
the majority of infections were viral. For our analysis
months within the period from January 1976 to Decem-
ber 1989 with the highest 5% of ARI notifications were
considered high exposure months (high ARI). As this cut
off was arbitrary we chose a second cut-off of the highest
10% to be able to check for the consistency of the results.
For each child it was established in which month of life
between the first month of pregnancy and age 1 year it was
exposed to high ARI.
Statistical analysis
For descriptive and logistic regression analyses high ARI
was analysed for the following disjoint exposure periods:
trimester 1, trimester 2, trimester 3, month of birth,
months 0–3, months 3–6, months 6–9 and months 9–12.
The periods were defined high ARI if high ARI was present
in at least one of the respective months.
Multivariate logistic regression analyses were performed
to establish the final models. We aimed to build models
with few covariates only. Therefore only factors confound-
ing the association between the exposure variables and
the outcome variables were included in the models. Age-
group, month of birth, family size, sex, area, parental
allergy and parental education were a priori considered as
potential confounder variables. Family size was taken as a
proxy variable for siblings because direct information
about siblings was not available from the questionnaires.
Factors were tested individually. Only factors causing a
change of more than 10% in the effect (odds ratio) of the
main exposure variable were considered to be relevant.
The final models included all confounding variables
found to be relevant in any of the models. This approach
was chosen to minimise the number of variables in the
model to make the model more stable.
In the next step, we aimed to examine our data in an
explorative way without confinement to the (mostly)
three-month periods described above. We used polyno-
mial distributed lags in a multivariate logistic regression
model to assess whether it yields similar results as the first
approach and can be used to describe the data. We had no
hypothesis on the timing of a potential vulnerable period
within the pre- and post-natal period. Since an epidemic
might have an effect during the months before and after
birth, a logistic model was used that included the expo-
sure in all months between 9th months before birth
(month of conception) and 12th month after birth.
Instead of entering 22 exposure terms into the model we
constrained the ß's to follow a polynomial function of
degree 6, to control for collinearity and to use less degrees
of freedom [16]. This model indicated the nature of the
lag structure between epidemics and the occurrence of the
outcome. Statistical analysis was performed with STATA
8.0 (Stata Corp., Texas, USA) and SAS version 8 (SAS Insti-
tute Inc, Carc, NC).
Results
Population characteristics and prevalence of atopic 
diseases
Data on atopic conditions and IgE results were available
for 4672 and 3955 (84.6%) of the 4673 eligible children,
respectively. One child was excluded because it had miss-
ing data on all atopic conditions measured. Table 1 sum-
marises the characteristics of the population and the
prevalence of allergic conditions. The majority of children
belonged to the oldest age-group (73.6%) because chil-
dren that participated in multiple surveys were assigned
the age of the last survey. Within the study population
asthma had been diagnosed in 2.6% of children, eczema
in 11.7% and hay fever in 6.8%. Inhalant sensitization
was prevalent in 27.6% and elevated total IgE in 16% of
children, respectively.
Acute respiratory infections (ARI)
The number of ARI notifications ranged from 10124 to
180137 ARI per month with a median of 35168 (period
January 1976 – December 1989). A notification number
greater than 70000 (corresponding to the upper 5%) was
defined high ARI. The following months were identified
as high ARI months: March 1976, 1979, 1981, 1983,
1984, 1986, 1988 and February 1980 and 1985. (figure 1)
Multivariate logistic regression analysis and polynomial 
distributed lag models
For multivariate logistic regression analysis confounding
of the association between high ARI exposure and the
atopic outcomes was tested for sex, parental allergy,Respiratory Research 2006, 7:81 http://respiratory-research.com/content/7/1/81
Page 4 of 8
(page number not for citation purposes)
parental education, area, age-group, family size and
month of birth. Age-group and month of birth con-
founded the association between high ARI exposure and
any of the atopic conditions and were therefore included
in the models.
The results from multivariate logistic regression models
using disjoint exposure periods and polynomial distrib-
uted lags were similar. Therefore, we used polynomial dis-
tributed lag-models in the description of the associations
between exposure to high ARI between pregnancy and the
first year of life and atopic conditions at school age. Fig-
ures 2a–g show the Odds ratios of atopic conditions
adjusted for age-group and month of birth. High ARI
exposure within the period between the beginning of
pregnancy and age one year was associated with overall
reduced odds of all atopic conditions. Exposure in the first
9 months of life showed the most pronounced effect and
was partly statistically significant for eczema, asthma, hay
fever, inhalant sensitization and total IgE. The protective
effects on inhalant sensitization seemed to be mainly
influenced by the effects on indoor allergen sensitization.
When the analyses were repeated for the highest 10% of
ARI notifications, the effects were less pronounced, but
still significant for hay fever, inhalant sensitization and
total IgE for months 3–6 and additionally for total sensi-
tization for month 6–9 and for asthma, eczema and
indoor allergen sensitization for the third trimester (data
not shown).
Discussion
According to the hygiene hypothesis, infections in early
life protect from allergic diseases [1]. Even though indirect
evidence for this hypothesis is plenty, direct investigations
of the associations between infections and atopic condi-
tions came to conflicting results. The majority of studies
measuring indirect markers of infections like siblings and
day care attendance has confirmed the hypothesis [2-4].
Studies measuring past infection via IgG antibodies more
consistently observed inverse associations with atopic
conditions [9,10] than studies measuring clinical infec-
tions [6,11,12]. Yet, positive antibody titres only measure
past immune response of the organism with the infectious
agent (infection) without any indication whether clinical
disease had actually taken place. Infection often repre-
sents sub- clinical infection (without symptoms) rather
than clinical infectious disease (with symptoms). Like-
wise in our study a high risk of exposure to acute respira-
tory infections is not a proxy for clinical diseases but more
likely a proxy for infection, a combination of sub-clinical
and clinical infection. In our cohort a high pre- and post-
natal risk of exposure to respiratory infectious agents was
associated with decreased frequencies of atopic condi-
tions at age 5–14 years. Interpreting the current literature
and our results, we propose that the previous negative
findings of studies investigating the associations between
clinical infections and atopic conditions [11,12] might
have been due to the fact that those studies considered
solely clinical diseases whereas clinical and sub-clinical
infection (exposure to infectious agents) in early life
might protect against atopic conditions. This concept
might also explain the strong and consistent findings of
sibling and day care effect [2-4] as both siblings and day
care increase the risk of exposure to infections rather than
representing clinical infections of the children. Moreover,
this concept would be in line with consistent findings of
inverse associations between non-pathogen microbial
stimulations (endotoxin, pro-biotics, farming environ-
ment) and atopic conditions [8,17,18].
Atopic conditions occur early in life. Therefore factors act-
ing in early life or during pregnancy are thought to play an
important role in the prevention of atopic diseases. The
results of several studies indicate that exposure to factors
related to the hygiene hypothesis before the first year of
life confer more protection than exposures at a later age
[3,4,6,8]. Responses of the immune system to specific
allergens and endotoxin have been shown to start already
in utero [5,7]. However, it is still not clear in which pre- or
post-natal period exposure to infection is most effective in
the prevention of atopic diseases. Most of the IgG studies
were cross-sectional [9,10]. Therefore the time-sequence
of events could not be established and methodological
limitations such as recall bias were unavoidable. In our
historical cohort study the observed protective effects of
pre- and post-natal high risk of exposure to infectious
agents on hay fever, specific and total sensitization at age
5–14 years were particularly pronounced in after birth
periods. In relation to asthma and eczema this confine-
ment was less clear. According to the current understand-
ing early priming of the immune system might result in a
lasting imbalance between Th1 and Th2 cells. Thus, it is
assumed that microbial stimuli confer protection against
allergies by the induction of "protective" Th1 immune
responses. However, a physiological Th1 deficit exists at
Number of acute respiratory infection notifications Figure 1
Number of acute respiratory infection notifications.Respiratory Research 2006, 7:81 http://respiratory-research.com/content/7/1/81
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birth [19,20]. In addition, neonatal dendritic cells have a
lower capacity to secrete IL-12, which is a key cytokine
needed for the priming of Th1-responses [21,22]. Thus it
is conceivable, that environmental factors may have a
stronger impact in the first year of life as compared to foe-
tal or neonatal periods. On the other hand, ARI most
Odds ratios (OR) for the associations between exposure to high ARI and different atopic conditions Figure 2
Odds ratios (OR) for the associations between exposure to high ARI and different atopic conditions. ORs have been adjusted 
for age group and month of birth and are shown with 95% confidence intervals.Respiratory Research 2006, 7:81 http://respiratory-research.com/content/7/1/81
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probably represent viral infections in the majority of
cases. Therefore, it is still possible that bacterial stimuli or
the combinations of bacterial and viral components or
several bacterial species have a stronger impact also on
foetal or neonatal immune responses. To our knowledge
this is the first study that was able to examine the vulner-
able period looking at both pre-natal and post-natal expo-
sure periods.
Another unresolved issue is the type of infection which is
thought to confer protection. Matricardi et al. found that
inverse associations between number of older siblings
and atopy were not completely mediated by hepatitis A
antibodies and concluded that hepatitis A is not the only
infection associated with low prevalence of atopy [9].
However, protective effects of infections have been mainly
described for gastrointestinal infections [23]. In combina-
tion with observations of an increased risk of atopic dis-
eases in children treated with antibiotics [12,24] and
protective effects of pro-biotic nutrition [17] a main role
of the gastrointestinal system is therefore assumed. This
notion has further been fuelled by findings of positive
associations between respiratory infections (e.g. respira-
tory syncytial virus (RSV)) and atopic diseases. Two expla-
nations have been proposed. One assumes that RSV-
infections primary damage the respiratory system. The
other one sees RSV infection facilitated by primary predis-
position or an already altered respiratory system [25].
However, there is also some evidence that the severity of
respiratory tract infections might influence the direction
of the observed effects on atopic conditions with less
severe infections resulting in a decreased risk [6,26]. If
lighter infections would be responsible for a protective
effect on atopic diseases then our hypothesis that sub-clin-
ical infections would also confer protection would fit.
Moreover, protective effects might not be refined to gas-
tro-intestinal infections.
We had the unique possibility to conduct a historical
cohort study with notification data of the German Demo-
cratic Republic thereby avoiding shortcomings of recall
bias while considering the time-sequence of events. How-
ever, potential limitations of the study have to be consid-
ered in the interpretation of our findings. Exposure to ARI
is a proxy measure of individual exposure to ARI therefore
measuring "risk of exposure" rather than individual expo-
sure. This might be more problematic when considering
false negative exposures. While it is likely that during the




Hay fever 316/4668 6.8
Inhalant allergen sensitization 1 * 1030/3737 27.6
Outdoor allergen sensitization 2 * 738/3737 19.8
Indoor allergen sensitization 3 * 631/3915 16.1
Elevated total IgE 4* 631/3955 16.0
Exposed to high ARI in period 5
Trimester 1 927/4672 19.8
Trimester 2 989/4672 21.2
Trimester 3 617/4672 13.2
Month of birth 223/4672 4.8
Months 0–3 573/4672 12.3
Months 3–6 653/4672 14.0
Months 6–9 817/4672 17.5
Months 9–12 738/4672 15.8
Area   Zerbst 1426/4672 30.5
Bitterfeld 1925/4672 41.2
Hettstett 1321/4672 28.3
Male sex 2464/4672 52.7
Age 5–7 years 205/4672 4.4
8–10 years 1027/4672 22.0
10–12 years 3440/4672 73.6
Parental allergy 6 1155/4567 25.3
High parental education 7 1924/4531 42.5
n/N = number of observations/total number of observations;
1 specific IgE against cat, mite, grass or birch >= 0.7 kU/l; 2specific IgE against grass or birch >= 0.7 kU/l; 3specific IgE against cat or mite >= 0.7 kU/
l; 4 total IgE >= 400 kU/l; The different sensitization denominatorsof result from different numbers of missing values.5 numbers do not add up to 
100% as children could be exposed to high ARI in more than one period; 6 at least one parent reported a history of asthma, hay fever or eczema; 7 
at least one parent completed high school;Respiratory Research 2006, 7:81 http://respiratory-research.com/content/7/1/81
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high exposure months, most children respectively moth-
ers will be exposed to the virus, many will likely also be
exposed in the lower exposure months. Even though we
think that it would only affect a small proportion of our
population this possible bias constitutes a potential con-
cern. However, for the vast majority of the population our
results should hold true. We measured the effect of the
highest 5% and 10% of ARI notifications – where contact
with infections was very likely even though clinical infec-
tions not necessarily had to occur. Thus, there was a high
probability that all individuals living in the study area at
that high ARI time were exposed to ARI. Non-differential
misclassification would bias the effects to unity. There-
fore, in case of non-differential misclassification the true
underlying effects would be even larger than the observed
effects. Moreover, it should be kept in mind that there is
no feasible-and-ideal way of measuring individual expo-
sure to the combination of clinical AND non-clinical
infections. Our exposure assessment inhibits weaknesses
but at the same time also confers some important advan-
tages, namely that it is at the same time a proxy for non-
clinical infection (similar to day care attendance and sib-
lings). Non-clinical infection also leads to an activation of
the immune system and consequently might confer some
of the protective effect on allergic diseases development
that has been proposed by the hygiene hypothesis. Con-
founding also has to be considered in the interpretation of
the results. However, when testing potential confounding
factors in our model, only age group and month of birth
confounded the associations between exposure to ARI
and any of the investigated conditions and were therefore
adjusted for. It was difficult to differentiate between the
effects of month of birth and high ARI. In crude analyses
month of the year was statistically significantly associated
with most of the atopic outcomes. However, when we
adjusted for month of birth, high ARI remained statisti-
cally significant. Moreover, the observed inverse associa-
tions between high ARI and specific sensitization were
mostly influenced by indoor allergen sensitization. The
opposite would have been expected if month of birth as a
proxy for exposure to pollen would have been the under-
lying causal factor. We therefore believe that the observed
inverse associations between high ARI and the atopic out-
comes were not entirely due to collinearity. Birth month
has been discussed as a potential risk factor of allergies.
However, the literature until now remained inconclusive
[27]. The protective effects were also pronounced for total
IgE. The interpretation for these findings is not clear to us.
Individual data in our analysis were collected at age 5–14
years. Therefore, children might have had a different ARI
exposure at birth time if they had moved to the study area
from other regions. We had only limited information
about the place of birth of the children. However, this
potential kind of exposure misclassification would also
have resulted in an attenuation of the effects, where the
true effect would have been larger. We had no data on
older siblings and used family size as a proxy variable.
Nevertheless, we think that family size is a good proxy var-
iable, because in Germany grandparents, aunts and uncles
normally don't live with the family. Therefore, family size
is mostly defined by the number of siblings.Multiple test-
ing might have constituted a further limitation of our
study. The analysis to identify the vulnerable period in
which exposure to infection might protect from develop-
ment of atopic conditions was explorative as we had no
hypothesis about the exact timing of this protective effect.
However, the consistency of our findings of a protective
effect of months 6–9 in relation to hay fever, specific and
total sensitization and the observation of slight dose
response relationship argue against merely chance find-
ings. Moreover, it seems plausible that the vulnerable
period for eczema precedes the vulnerable periods for hay
fever and asthma, as this is the order in which the respec-
tive clinical conditions manifest.
Conclusion
Our results support the hygiene hypothesis and add evi-
dence that a high risk of exposure as early as the pre- and
post-natal period might be associated with decreased fre-
quencies of atopic diseases. The post-natal period thereby
seems to be particularly important. Sub-clinical infections
rather than clinical infections might lead to the protective
effects of infections on atopic diseases. The protective
effect of infections might also be conferred by respiratory
tract infections.
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